V

Verastem Oncology

73 employees

Verastem is a biopharmaceutical company that focuses on discovering and developing novel drugs that selectively target cancer stem cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biotechnology
pharmaceutical
CLL
Oncology
Pharmaceutical
Lymphoma
cancer research
hematology
NHL
T Cell Lymphoma
clinical trials
cancer
Biopharma
blood cancer

Date founded

2010

Funding rounds raised

Total raised

$32M

from 16 investors over 16 rounds

V

Verastem Oncology raised $25M on March 28, 2022

Investors: Oxford Finance LLC

V

Verastem Oncology raised $25M on March 23, 2017

Investors: Hercules Capital, Inc.

V

Verastem Oncology raised $20M on November 11, 2011

Investors: Cardinal Partners (CP), Bessemer Venture Partners, MPM Capital and Longwood Fund

V

Verastem Oncology raised $32M on July 14, 2011

Investors: Advanced Technology Ventures, Cardinal Partners (CP), Astellas Venture Capital L.L.C., Bessemer Venture Partners, MPM Capital and Longwood Fund

V

Verastem Oncology raised $16M on November 16, 2010

Investors: Cardinal Partners (CP), Longwood Fund, MPM Capital and Bessemer Venture Partners

FAQ